首页> 美国卫生研究院文献>Lippincott Williams Wilkins Open Access >New Answers to Old Conundrums: What Antibodies Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report
【2h】

New Answers to Old Conundrums: What Antibodies Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report

机译:对旧难题的新答案:抗体外泌体和炎症小体如何带动对话。加拿大国家移植研究计划国际峰会报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibody-mediated injury is a major cause of allograft dysfunction and loss. Antibodies to ABH(O) blood group antigens are classic mediators of ABO-incompatible graft rejection, whereas donor-specific anti-HLA antibodies and, more recently, autoantibodies are appreciated as important contributors to allograft inflammation and dysfunction. In August 2016, the International Summit of the Canadian National Transplant Research Program focused on recent advances in the field of antibody-mediated rejection. Here, we describe work presented and discussed at the meeting, with a focus on 3 major themes: the importance of (1) natural antibodies and autoantibodies, (2) tissue injury–derived exosomes and autoimmunity, (3) inflammasome activation and innate immune responses in regulating allograft inflammation and dysfunction. Finally, we explore novel areas of therapeutic intervention that have recently emerged from these 3 major and overlapping fields of transplantation research.
机译:抗体介导的损伤是同种异体移植功能障碍和丢失的主要原因。 ABH(O)血型抗原的抗体是ABO不相容移植排斥的经典介体,而供体特异性抗HLA抗体和最近的自身抗体被认为是同种异体移植炎症和功能障碍的重要因素。 2016年8月,加拿大国家移植研究计划国际峰会重点关注了抗体介导的排斥反应领域的最新进展。在这里,我们描述会议上介绍和讨论的工作,并着重于三个主要主题:(1)天然抗体和自身抗体的重要性,(2)组织损伤衍生的外来体和自身免疫性,(3)炎性体激活和先天免疫在调节同种异体移植炎症和功能障碍中的反应。最后,我们探索了最近在这三个主要且重叠的移植研究领域中出现的新型治疗干预领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号